z-logo
open-access-imgOpen Access
Early initiation of SGLT2 inhibitors is important, irrespective of ejection fraction: SOLOIST‐WHF in perspective
Author(s) -
Verma Subodh,
Anker Stefan D.,
Butler Javed,
Bhatt Deepak L.
Publication year - 2020
Publication title -
esc heart failure
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.787
H-Index - 25
ISSN - 2055-5822
DOI - 10.1002/ehf2.13148
Subject(s) - heart failure , empagliflozin , medicine , ejection fraction , dapagliflozin , cardiology , valsartan , canagliflozin , ace inhibitor , diabetes mellitus , angiotensin converting enzyme , type 2 diabetes , blood pressure , endocrinology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom